JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266960

Human SLC15A3 knockout A549 cell line

Human SLC15A3 knockout A549 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SLC15A3 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

別名を表示する

FLJ26631, OCTP, Osteoclast transporter, PHT2, PTR3, Peptide transporter 3, Peptide/histidine transporter 2, S15A3_HUMAN, Solute carrier family 15 (oligopeptide transporter) member 3, Solute carrier family 15 member 3

1 Images
Sanger Sequencing - Human SLC15A3 knockout A549 cell line (AB266960)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC15A3 knockout A549 cell line (AB266960)

Homozygous : 1 bp insertion in exon1

Key facts

細胞タイプ

A549

生物種

Human

組織

Lung

製品の状態

Liquid

form

ノックアウト検証方法

Sanger Sequencing

ノックアウト変異

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

疾病

Carcinoma

製品の詳細

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

製品内容

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266960-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255450 Human wild-type A549 cell line", "number":"AB266960-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266960 Human SLC15A3 knockout A549 cell line", "number":"AB266960-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266960-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255450 Human wild-type A549 cell line", "number":"AB266960-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266960 Human SLC15A3 knockout A549 cell line", "number":"AB266960-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266960-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266960 Human SLC15A3 knockout A549 cell line", "number":"AB266960-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266960-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266960 Human SLC15A3 knockout A549 cell line", "number":"AB266960-CMP01", "productcode":"" } ] } } }

出荷温度及び保存条件

遺伝子名
SLC15A3
遺伝子編集のタイプ
Knockout
遺伝子編集の方法
CRISPR technology
ノックアウト検証方法
Sanger Sequencing
接合型
Homozygous
出荷温度
Dry Ice
短期保存温度
-196°C
長期保存温度
-196°C

取り扱い方法

初回取り扱いガイドライン

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

継代培養ガイドライン
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
培養培地

F-12K + 10% FBS

凍結保存培地

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

SLC15A3 also known as Peptide/Histidine Transporter 2 (PHT2) is a transporter protein involved in dipeptide and oligopeptide transport across cellular membranes. This protein has a molecular mass of approximately 95 kDa. SLC15A3 is mainly expressed in a variety of tissues including the kidney lung and immune system cells. It plays an important role in maintaining amino acid balance within cells by facilitating the entry of peptides.
Biological function summary

SLC15A3 functions to regulate the immune system by modulating peptide availability within immune cells. This transporter is a part of the larger solute carrier (SLC) family which includes several transporters involved in nutrient absorption and cellular metabolism. SLC15A3 does not form part of a known complex but interacts with other proteins within the immune function pathways thereby reinforcing its role in cellular defense mechanisms.

Pathways

SLC15A3 has important roles in the immune response and antimicrobial peptide pathways. It is involved in pathways such as the NF-kB signaling aiding in immune activation and response. SLC15A3 works alongside proteins like TLRs (Toll-like receptors) and MyD88 providing pathways with vital peptides required for immune signal transduction and response.

SLC15A3 has relations to inflammatory diseases and certain types of cancers. Disruptions in SLC15A3 expression or function can contribute to inappropriate immune responses leading to chronic inflammation. Additionally altered activity levels can influence tumor growth due to changes in peptide transport and amino acid availability which affects proteins like mTOR involved in regulating cell growth and proliferation. Understanding SLC15A3's role offers potential for therapeutic targets in these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

製品プロトコール

ターゲットの情報

See full target information SLC15A3

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com